home / stock / hltrf / hltrf news

HLTRF News and Press, HLS Therapeutics Inc From 04/01/19

Stock Information
Company Name: HLS Therapeutics Inc
Stock Symbol: HLTRF
Market: OTC
Website: hlstherapeutics.com
Menu
HLTRF HLTRF Quote HLTRF Short HLTRF News HLTRF Articles HLTRF Message Board
Get HLTRF Alerts

News, Short Squeeze, Breakout and More Instantly...
HLTRF - Amarin's Vascepa granted priority review status from Health Canada

Health Canada grants priority review status for Amarin's (NASDAQ: AMRN ) licensee, HLS Therapeutics' ( OTCPK:HLTRF ) New Drug Submission (“NDS”) for Vascepa (icosapent ethyl) capsules. More news on: Amarin Corporation plc, HLS Therapeutics Inc., Healthcare stocks news, ...
HLTRF - HLS Therapeutics reports Q4 results

HLS Therapeutics ( OTCPK:HLTRF ): Q4 GAAP EPS of $0.01. More news on: HLS Therapeutics Inc., Earnings news and commentary, Tech stocks news, Read more ...

HLTRF - HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference

HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference Canada NewsWire TORONTO, Feb. 19, 2019 TORONTO , Feb. 19, 2019 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a specialty pharmaceutical company focused on cent...

Previous 10 Next 10